Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Journal of Infection and Public Health|April 26, 2023
Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin - A real-world data and retrospective cost analysisChristoph T Baltin, Carolin Wulf, Robert Rongisch, et al.
Archives of Dermatology|November 23, 2006
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigusStefan Beissert, Thomas Werfel, Uta Frieling, et al.
Arthritis Research & Therapy|March 6, 2009
High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacyNicolas Hunzelmann, Pia Moinzadeh, Ekkehard Genth, et al.
Archives of Dermatology|December 19, 2007
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoidStefan Beissert, Thomas Werfel, Uta Frieling, et al.
Plos Pathogens|March 21, 2007
Transport of Streptococcus pneumoniae capsular polysaccharide in MHC Class II tubulesTom Li Stephen, Mario Fabri, Laura Groneck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activationPeter A Sieling, Preston J Hill, Karen M Dobos, et al.
Scientific Reports|December 5, 2024
New insights into the structural role of EMILINs within the human skin microenvironmentAlvise Schiavinato, Fady Marcous, Alexandra V Zuk, et al.
Plos Pathogens|September 26, 2009
Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinkingJanina Mertens, Mario Fabri, Alessandra Zingarelli, et al.
Rheumatology (Oxford, England)|October 12, 2022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by regionAlain Lescoat, Dörte Huscher, Nils Schoof, et al.
Pageof 16